Open access
Oct 2026
RETROSPECTIVE STUDY OF EFFICACY AND SAFETY OF THE COMBINATION LINAGLIPTIN, EMPAGLIFLOZIN, METFORMIN IN THE MANAGEMENT OF TYPE 2 DIABETES IN INDIA IN THE REAL-WORLD SETTING
Background: Type 2 diabetes mellitus (T2DM) is a progressive disorder with high cardiovascular (CV) risk, often inadequately controlled on monotherapy. This study aimed to evaluate real-world efficacy, safety, CV outcomes, tolerability and adherence of the empagliflozin, sitagliptin and metformin fixed-dose combination...
Nandkishor Shingne, Masiha Asar, Abdul Lateef Shaikh et al.
· World Journal of Advanced Re... · 0 citations